Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 mai 2025 09h08 HE | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Market Analysis Report, April 2025 Edition - Biosimilar Approvals Surge to Record High, A Key Opportunity for Biologic CMOs

Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, April 2025" has been added to ResearchAndMarkets.com's offering. The Bio/Pharmaceutical Outsourcing Report...
08 juin 2022 04h23 HE | Source: Research and Markets

Biologic API CDMO Benchmarking Report 2022: Comprehensive Analysis of Current Outsourcing Trends and Practices

Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Biologic API CDMO Benchmarking (7th Ed.)" report has been added to ResearchAndMarkets.com's offering. The Biologic API CDMO Benchmarking (7th...
22 févr. 2022 05h18 HE | Source: Research and Markets

Global Biologic Drug Product CMO Benchmarking Market 2022: Biologic Drug Product CMO Competitive Landscape and Company Service Quality Profiles

Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Biologic Drug Product CMO Benchmarking" report has been added to ResearchAndMarkets.com's offering. The Biologic Drug Product CMO Benchmarking (5th...
05 mars 2021 05h18 HE | Source: Research and Markets

6th Edition Biologic API Contract Manufacturer Quality Benchmarking Market Study

Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Biologic API Contract Manufacturer Quality Benchmarking (6th Edition)" report has been added to ResearchAndMarkets.com's offering. This Biologic API...
02 mars 2021 07h28 HE | Source: Research and Markets

Global Biologic Drug Product Contract Manufacturer Quality Benchmarking Study 2021

Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Biologic Drug Product Contract Manufacturer Quality Benchmarking (4th Edition)" report has been added to ResearchAndMarkets.com's offering. This...
08 sept. 2020 07h33 HE | Source: Research and Markets

Opportunities in the Contract Manufacturing Market in China - China's mAb Therapeutics is Forecast to Grow to $26 Billion by 2030

Dublin, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The "Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities" report has been added to...